Aclaris Therapeutics (ACRS)
Q4 2018 Earnings Conference Call
March 18, 2019 08:00 ET
Company Participants
Kamil Ali-Jackson - Co-Founder and Chief Legal Officer
Neal Walker - Co-Founder Chief Executive Officer, President and Director
Stuart Shanler - Co-Founder and Chief Scientific Officer
Jeff Wayne - Interim Chief Commercial Officer
Frank Ruffo - Co-Founder and Chief Financial Officer
David Gordon - Chief Medical Officer
Conference Call Participants
Blair Cohen - Guggenheim Securities
Timothy Lugo - William Blair
Presentation
Operator
Good day, ladies and gentlemen, and welcome to the Aclaris Therapeutics Fourth Quarter 2018 Earnings Conference Call. [Operator